Catherine Marie Mendenhall, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 25453 Bann St, Manhattan, IL 60442 Phone: 773-343-6273 |
News Archive
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, today announced the initiation of a Phase 1 clinical study to assess the safety, dosimetry and tolerability of LMI1195, a novel F-18 small molecule tracer for imaging cardiac neuronal function, in healthy subjects, undergoing positron emission tomography (PET) imaging.
TetraLogic Pharmaceuticals announced today that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, dose-escalation study evaluating the safety and tolerability of TL32711 in adults with solid tumors or lymphoma refractory to standard therapies. The study will also assess the pharmacokinetics, pharmacodynamics and anti-tumor activity of TL32711.
The popular dietary supplements glucosamine and chondroitin sulfate proved no better than a placebo in relieving osteoarthritis knee pain in most participants of a major national trial.
Reuters/The Washington Post: An electronic medical system first introduced in 2007 has shown a 20 percent drop in hospital deaths - the equivalent of about 36 lives saved - over 18-months at Lucile Packard Children's Hospital in Palo Alto California, doctors there have found. The system, a computerized physician order entry, or CPOE, allows "doctors to relay prescriptions to pharmacists without delay, and without the need for the pharmacist to decipher doctors' scrawl."
Bowel cancer or colon cancer was till now considered a disease that affected elderly men. Recent trends however show that it is affecting more and more Australians in a younger age group.
› Verified 1 days ago